HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1301	19539 Freichel C, Neumann M, Ballard T, Muller V, Woolley M, et al. Age-dependent cognitive decline and amygdala pathology in alpha- synuclein transgenic mice NEUROBIOLOGY OF AGING. 2007 SEP; 28 (9): 1421-1435	20	26	38	53
1302	19934 Levy JA, Chelune GJ Cognitive-behavioral profiles of Neurodegenerative dementias: Beyond Alzheimer's disease JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2007 DEC; 20 (4): 227-238	0	7	38	154
1303	20026 Zhu XW, Perry G, Smith MA Two hits and you're out? A novel mechanistic hypothesis of Alzheimer disease ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 191-204	0	2	38	132
1304	20219 Kwong LK, Uryu K, Trojanowski JQ, Lee VMY TDP-43 proteinopathies: Neurodegenerative protein misfolding diseases without amyloidosis NEUROSIGNALS. 2008; 16 (1): 41-51	37	37	38	59
1305	20319 Chesselet MF In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease? EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 22-27	30	37	38	58
1306	20946 Ye L, Velasco A, Fraser G, Beach TG, Sue L, et al. In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain JOURNAL OF NEUROCHEMISTRY. 2008 MAY; 105 (4): 1428-1437	9	17	38	51
1307	21027 Braak H, Del Tredici K Invited Article: Nervous system pathology in sporadic Parkinson disease NEUROLOGY. 2008 MAY 13; 70 (20): 1916-1925	33	68	38	77
1308	21259 Deters N, Ittner LM, Gotz J Divergent phosphorylation pattern of tau in P301L tau transgenic mice EUROPEAN JOURNAL OF NEUROSCIENCE. 2008 JUL; 28 (1): 137-147	12	13	38	47
1309	21490 Park JY, Paik SR, Jou I, Park SM Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: Implications for Parkinson's disease GLIA. 2008 AUG 15; 56 (11): 1215-1223	7	11	38	57
1310	21559 Lo Bianco C, Shorter J, Regulier E, Lashuel H, Iwatsubo T, et al. HsP104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease JOURNAL OF CLINICAL INVESTIGATION. 2008 SEP; 118 (9): 3087-3097	15	20	38	69
#	Date / Author / Journal	LCS	GCS	LCR	CR
1311	21918 de Vries HE, Witte M, Hondius D, Rozermuller AJM, Drukarch B, et al. Nrf2-induced antioxidant Protection: A Promising target to counteract ROS-mediated damage in neurodegenerative disease? FREE RADICAL BIOLOGY AND MEDICINE. 2008 NOV 15; 45 (10): 1375-1383	3	25	38	195
1312	21973 Aarsland D, Beyer MK, Kurz MW Dementia in Parkinson's disease CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 676-682	7	11	38	81
1313	22386 Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, et al. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation JOURNAL OF NEUROCHEMISTRY. 2009 JAN; 108 (1): 33-43	5	12	38	51
1314	23119 van Rooijen BD, Claessens MMAE, Subramaniam V Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2009 JUN; 1788 (6): 1271-1278	6	8	38	63
1315	23138 Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C The genetics of Parkinson's syndromes: a critical review CURRENT OPINION IN GENETICS & DEVELOPMENT. 2009 JUN; 19 (3): 254-265	12	26	38	95
1316	23498 Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, et al. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin JOURNAL OF NEUROCHEMISTRY. 2009 AUG; 110 (3): 1082-1094	20	20	38	55
1317	23659 Riedel M, Goldbaum O, Richter-Landsberg C alpha-Synuclein Promotes the Recruitment of Tau to Protein Inclusions in Oligodendroglial Cells: Effects of Oxidative and Proteolytic Stress JOURNAL OF MOLECULAR NEUROSCIENCE. 2009 SEP; 39 (1-2): 226-234	4	4	38	50
1318	24025 Farin A, Liu CY, Langmoen IA, Apuzzo MLJ BIOLOGICAL RESTORATION OF CENTRAL NERVOUS SYSTEM ARCHITECTURE AND FUNCTION: PART 3-STEM CELL- AND CELL-BASED APPLICATIONS AND REALITIES IN THE BIOLOGICAL MANAGEMENT OF CENTRAL NERVOUS SYSTEM DISORDERS: TRAUMATIC, VASCULAR, AND EPILEPSY DISORDERS NEUROSURGERY. 2009 NOV; 65 (5): 831-859	0	0	38	165
1319	24042 Wang YP, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing HUMAN MOLECULAR GENETICS. 2009 NOV 1; 18 (21): 4153-4170	20	37	38	72
1320	24175 Botella JA, Bayersdorfer F, Gmeiner F, Schneuwly S Modelling Parkinson's Disease in Drosophila NEUROMOLECULAR MEDICINE. 2009 DEC; 11 (4): 268-280	1	2	38	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
1321	24184 Ahlskog JE Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease PARKINSONISM & RELATED DISORDERS. 2009 DEC; 15 (10): 721-727	1	3	38	118
1322	24261 Butterfield SM, Lashuel HA Amyloidogenic Protein Membrane Interactions: Mechanistic Insight from Model Systems ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2010; 49 (33): 5628-5654	0	1	38	224
1323	24324 Hunter KU, Yarbrough C, Ciacci J Gene- and Cell-Based Approaches for Neurodegenerative Disease FRONTIERS IN BRAIN REPAIR. 2010; 671: 117-130	0	0	38	115
1324	24422 Run XQ, Liang ZH, Gong CX Anesthetics and Tau Protein: Animal Model Studies JOURNAL OF ALZHEIMERS DISEASE. 2010; 22: S49-S55	0	0	38	83
1325	24566 De Kimpe L, Scheper W From Alpha to Omega with A beta: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimer's Disease CURRENT MEDICINAL CHEMISTRY. 2010 JAN; 17 (3): 198-212	0	2	38	177
1326	24756 Nagai Y, Fujikake N, Popiel HA, Wada K Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 188-197	0	1	38	114
1327	24791 Lemere CA, Masliah E Can Alzheimer disease be prevented by amyloid-beta immunotherapy? NATURE REVIEWS NEUROLOGY. 2010 FEB; 6 (2): 108-119	4	22	38	131
1328	25075 Haque F, Pandey AP, Cambrea LR, Rochet JC, Hovis JS Adsorption of alpha-Synuclein on Lipid Bilayers: Modulating the Structure and Stability ofProtein Assemblies JOURNAL OF PHYSICAL CHEMISTRY B. 2010 MAR 25; 114 (11): 4070-4081	0	1	38	65
1329	25245 Wang MS, Boddapati S, Emadi S, Sierks MR Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model BMC NEUROSCIENCE. 2010 APR 30; 11: Art. No. 57	0	0	38	60
1330	25271 Garbern JY, Neumann M, Trojanowski JQ, Lee VMY, Feldman G, et al. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition BRAIN. 2010 MAY; 133: 1391-1402	1	1	38	84
#	Date / Author / Journal	LCS	GCS	LCR	CR
1331	25319 Schwach G, Tschemmernegg M, Pfragner R, Ingolic E, Schreiner E, et al. Establishment of Stably Transfected Rat Neuronal Cell Lines Expressing alpha-Synuclein GFP Fusion Proteins JOURNAL OF MOLECULAR NEUROSCIENCE. 2010 MAY; 41 (1): 80-88	1	1	38	57
1332	25754 Buee L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, et al. From tau phosphorylation to tau aggregation: what about neuronal death? BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 967-972	0	0	38	48
1333	25939 Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, et al. Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43 JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 AUG 20; 285 (34): 26304-26314	2	2	38	77
1334	25985 Castellani RJ, Rolston RK, Smith MA Alzheimer Disease DM DISEASE-A-MONTH. 2010 SEP; 56 (9): 484-546	0	1	38	303
1335	26539 Bosco DA, Landers JE Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 779-790	0	0	38	157
1336	26563 Tenreiro S, Outeiro TF Simple is good: yeast models of neurodegeneration FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 970-979	0	1	38	97
1337	26596 Li J, Li XY, Feng DF, Pan DC Biomarkers Associated With Diffuse Traumatic Axonal Injury: Exploring Pathogenesis, Early Diagnosis, and Prognosis JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2010 DEC; 69 (6): 1610-1618	0	0	38	91
1338	26617 Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, et al. Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings NEUROLOGICAL SCIENCES. 2010 DEC; 31 (6): 741-749	0	0	38	76
1339	26876 Braak H, Del Tredici K The pathological process underlying Alzheimer's disease in individuals under thirty ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 171-181	1	1	38	97
1340	26935 Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, et al. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review NEUROLOGICAL SCIENCES. 2011 FEB; 32 (1): 9-16	0	0	38	83
#	Date / Author / Journal	LCS	GCS	LCR	CR
1341	26951 Cho MK, Kim HY, Fernandez CO, Becker S, Zweckstetter M Conserved core of amyloid fibrils of wild type and A30P mutant alpha- synuclein PROTEIN SCIENCE. 2011 FEB; 20 (2): 387-395	0	0	38	55
1342	26959 Nasstrom T, Fagerqvist T, Barbu M, Karlsson M, Nikolajeff F, et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties FREE RADICAL BIOLOGY AND MEDICINE. 2011 FEB 1; 50 (3): 428-437	0	0	38	62
1343	27022 Soper JH, Kehm V, Burd CG, Bankaitis VA, Lee VMY Aggregation of alpha-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis JOURNAL OF MOLECULAR NEUROSCIENCE. 2011 MAR; 43 (3): 391-405	0	0	38	91
1344	2625 Trojanowski JQ, SCHMIDT ML, SHIN RW, BRAMBLETT GT, RAO D, et al. ALTERED TAU AND NEUROFILAMENT PROTEINS IN NEURODEGENERATIVE DISEASES - DIAGNOSTIC IMPLICATIONS FOR ALZHEIMERS-DISEASE AND LEWY BODY DEMENTIAS BRAIN PATHOLOGY. 1993 JAN; 3 (1): 45-54	187	187	37	89
1345	3985 SHIN RW, Lee VMY, Trojanowski JQ NEUROFIBRILLARY PATHOLOGY AND ALUMINUM IN ALZHEIMERS-DISEASE HISTOLOGY AND HISTOPATHOLOGY. 1995 OCT; 10 (4): 969-978	23	23	37	135
1346	4591 Mandell JW, Banker GA A spatial gradient of tau protein phosphorylation in nascent axons JOURNAL OF NEUROSCIENCE. 1996 SEP 15; 16 (18): 5727-5740	51	128	37	98
1347	4995 Dickson DW The pathogenesis of senile plaques JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1997 APR; 56 (4): 321-339	136	360	37	167
1348	6066 Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, et al. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M JOURNAL OF NEUROSCIENCE. 1998 JUN 1; 18 (11): 4008-4021	7	0	37	91
1349	6487 Gartner U, Janke C, Holzer M, Vanmechelen E, Arendt T Postmortem changes in the phosphorylation state of tau-protein in the rat brain NEUROBIOLOGY OF AGING. 1998 NOV-DEC; 19 (6): 535-543	16	20	37	55
1350	7733 Ekinci FJ, Shea TB Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC BRAIN RESEARCH. 1999 DEC 11; 850 (1-2): 207-216	1	11	37	79
#	Date / Author / Journal	LCS	GCS	LCR	CR
1351	7757 Jellinger KA Morphological substrates of mental dysfunction in Lewy body disease: an update ADVANCES IN DEMENTIA RESEARCH. 2000; : 185-212	0	0	37	150
1352	7822 Mizuno Y, Hattori N, Asakawa S, Shimura H, Mori H, et al. Progress in familial Parkinson's disease JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2000; 28 (3): 143-157	0	0	37	88
1353	7837 Jellinger KA Morphological substrates of mental dysfunction in Lewy body disease: an update JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 185-212	0	34	37	151
1354	8107 Chambers CB, Sigurdsson EM, Hejna MJ, Lorens SA, Lee JM, et al. Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression EXPERIMENTAL NEUROLOGY. 2000 MAR; 162 (1): 158-170	5	15	37	75
1355	8253 Probst A, Gotz J, Wiederhold KH, Tolnay M, Mistl C, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein ACTA NEUROPATHOLOGICA. 2000 MAY; 99 (5): 469-481	155	155	37	57
1356	8493 Barbas H Connections underlying the synthesis of cognition, memory, and emotion in primate prefrontal cortices BRAIN RESEARCH BULLETIN. 2000 JUL 15; 52 (5): 319-330	5	200	37	183
1357	8586 van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, et al. Neuropathology in mice expressing human alpha-synuclein JOURNAL OF NEUROSCIENCE. 2000 AUG 15; 20 (16): 6021-6029	256	275	37	58
1358	8809 Wong NKY, He BP, Strong MJ Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS) JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 NOV; 59 (11): 972-982	55	78	37	84
1359	8825 Arendt T Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain NEUROBIOLOGY OF AGING. 2000 NOV-DEC; 21 (6): 783-796	14	46	37	282
1360	8840 Yamada K, Nabeshima T Animal models of Alzheimer's disease and evaluation of anti-dementia drugs PHARMACOLOGY & THERAPEUTICS. 2000 NOV; 88 (2): 93-113	7	62	37	281
#	Date / Author / Journal	LCS	GCS	LCR	CR
1361	8849 Julien JP, Beaulieu JM Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? JOURNAL OF THE NEUROLOGICAL SCIENCES. 2000 NOV 1; 180 (1-2): 7-14	23	50	37	59
1362	9005 Halliwell B Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment DRUGS & AGING. 2001; 18 (9): 685-716	37	422	37	414
1363	9572 Arendt T Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2001 JUN; 19 (3): 231-245	8	35	37	280
1364	9787 Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, et al. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments JOURNAL OF NEUROSCIENCE. 2001 AUG 15; 21 (16): 6026-6035	32	32	37	49
1365	9830 Miyasaka T, Morishima-Kawashima M, Ravid R, Kamphorst W, Nagashima K, et al. Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 SEP; 60 (9): 872-884	18	18	37	44
1366	10817 Bian F, Nath R, Sobocinski G, Booher RN, Lipinski WJ, et al. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice JOURNAL OF COMPARATIVE NEUROLOGY. 2002 MAY 6; 446 (3): 257-266	29	54	37	70
1367	11942 Riess O, Berg D, Kruger R, Schulz JB Therapeutic strategies for Parkinson's disease based on data derived from genetic research JOURNAL OF NEUROLOGY. 2003 FEB; 250: 3-10	1	1	37	90
1368	12244 Braak H, Rub U, Gai WP, Del Tredici K Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen JOURNAL OF NEURAL TRANSMISSION. 2003 MAY; 110 (5): 517-536	49	117	37	115
1369	12544 Mishizen-Eberz AJ, Guttmann RP, Giasson BI, Day GA, Hodara R, et al. Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro JOURNAL OF NEUROCHEMISTRY. 2003 AUG; 86 (4): 836-847	57	57	37	52
1370	12665 Lin H, Zhai JB, Nie ZY, Wu JH, Meinkoth JL, et al. Neurofilament RNA causes neu rodegene ration with accumulation of ubiquitinated aggregates in cultured motor neurons JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 SEP; 62 (9): 936-950	6	6	37	80
#	Date / Author / Journal	LCS	GCS	LCR	CR
1371	12685 Phinney AL, Horne P, Yang J, Janus C, Bergeron C, et al. Mouse models of Alzheimer's disease: The long and filamentous road NEUROLOGICAL RESEARCH. 2003 SEP; 25 (6): 590-600	11	26	37	121
1372	12751 Van Deerlin VM, Gill LH, Farmer JM, Trojanowski JQ, Lee VMY Familial frontotemporal dementia: From gene discovery to clinical molecular diagnostics CLINICAL CHEMISTRY. 2003 OCT; 49 (10): 1717-1725	7	7	37	74
1373	12898 Liem RKH, Leung CL Neuronal intermediate filament overexpression and neurodegeneration in transgenic mice EXPERIMENTAL NEUROLOGY. 2003 NOV; 184 (1): 3-8	4	7	37	69
1374	12914 Ling Y, Morgan K, Kalsheker N Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2003 NOV; 35 (11): 1505-1535	9	62	37	308
1375	12919 Stefani M, Dobson CM Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution JOURNAL OF MOLECULAR MEDICINE-JMM. 2003 NOV; 81 (11): 678-699	65	491	37	200
1376	12930 Ardley HC, Scott GB, Rose SA, Tan NGS, Markham AF, et al. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin MOLECULAR BIOLOGY OF THE CELL. 2003 NOV; 14 (11): 4541-4556	26	63	37	95
1377	13318 Gong CX, Liu F, Wu GX, Rossie S, Wegiel J, et al. Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5 JOURNAL OF NEUROCHEMISTRY. 2004 JAN; 88 (2): 298-310	12	22	37	75
1378	13625 Zhou WB, Freed CR Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 12; 279 (11): 10128-10135	16	22	37	48
1379	14016 Hoyer WG, Cherny D, Subramaniam V, Jovin TM Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy JOURNAL OF MOLECULAR BIOLOGY. 2004 JUN 25; 340 (1): 127-139	16	48	37	60
1380	14038 Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, et al. Intra- and extracellular AB and PHF in clinically evaluated cases of Alzheimer's disease HISTOLOGY AND HISTOPATHOLOGY. 2004 JUL; 19 (3): 823-844	10	38	37	125
#	Date / Author / Journal	LCS	GCS	LCR	CR
1381	15382 Liazoghli D, Perreault S, Micheva KD, Desjardins M, Leclerc N Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons AMERICAN JOURNAL OF PATHOLOGY. 2005 MAY; 166 (5): 1499-1514	11	15	37	80
1382	15595 Masliah E, Rockenstein E, Adame A, Alford M, Crews L, et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease NEURON. 2005 JUN 16; 46 (6): 857-868	75	103	37	82
1383	15661 Hernandez F, Engel T, Gomez-Ramos A, Perez M, Avila J Characterization of Alzheimer paired helical filaments by electron microscopy MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 121-125	1	1	37	78
1384	15920 Kuan WL, Barker RA New therapeutic approaches to Parkinson's disease including neural transplants NEUROREHABILITATION AND NEURAL REPAIR. 2005 SEP; 19 (3): 155-181	4	12	37	338
1385	16358 Smith WW, Jiang HB, Pei Z, Tanaka Y, Morita H, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity HUMAN MOLECULAR GENETICS. 2005 DEC 15; 14 (24): 3801-3811	55	93	37	71
1386	16678 Khlistunova I, Biernat J, Wang YP, Pickhardt M, von Bergen M, et al. Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JAN 13; 281 (2): 1205-1214	64	79	37	57
1387	16840 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation JOURNAL OF ALZHEIMERS DISEASE. 2006 MAR; 9 (1): 1-12	9	23	37	119
1388	17184 Jenner P, Olanow CW The pathogenesis of cell death in Parkinson's disease NEUROLOGY. 2006 MAY 23; 66 (10): S24-S36	6	46	37	119
1389	17634 Engel T, Lucas JJ, Gomez-Ramos P, Moran MA, Avila J, et al. Cooexpression of FTDP-17 tau and GSK-3 beta in transgenic mice induce tau polymerization and neurodegeneration NEUROBIOLOGY OF AGING. 2006 SEP; 27 (9): 1258-1268	23	38	37	51
1390	17743 Chua CEL, Tang BL alpha-synuclein and Parkinson's disease: the first roadblock JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2006 OCT-DEC; 10 (4): 837-846	8	14	37	73
#	Date / Author / Journal	LCS	GCS	LCR	CR
1391	18113 Li WK, Lee VMY Characterization of two VQIXXK motifs for tau fibrillization in vitro BIOCHEMISTRY. 2006 DEC 26; 45 (51): 15692-15701	7	10	37	62
1392	18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147	6	30	37	167
1393	19303 Korecka JA, Verhaagen J, Hol EM Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 425-446	1	18	37	163
1394	19434 Chun W, Johnson GVW Activation of glycogen synthase kinase 3 beta promotes the intermolecular association of tau - The use of fluorescence resonance energy transfer microscopy JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 10; 282 (32): 23410-23417	7	9	37	63
1395	19618 Schipper HM The role of biologic markers in the diagnosis of Alzheimer's disease ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 325-332	0	6	37	90
1396	20022 Nunomura A, Moreira PI, Zhu XW, Cash AD, Smith MA, et al. Role of oxidative insult and neuronal survival in Alzheimer's and Parkinson's diseases ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 133-148	0	1	37	120
1397	20073 Aarsland D, Kurz M, Beyer M, Bronnick K, Nore SP, et al. Early discriminatory diagnosis of dementia with Lewy bodies DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008; 25 (3): 195-205	8	11	37	100
1398	20143 Ding HP, Johnson GVW The last tangle of tau JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 441-447	3	4	37	54
1399	20665 Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, et al. The early neuropsychological and behavioral characteristics of Frontotemporal dementia NEUROPSYCHOLOGY REVIEW. 2008 MAR; 18 (1): 91-102	9	17	37	87
1400	20713 Lee JT, Wheeler TC, Li L, Chin LS Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death HUMAN MOLECULAR GENETICS. 2008 MAR 15; 17 (6): 906-917	16	25	37	74

Date / Author / Journal

LCS

GCS

LCR

1301

19539 Freichel C, Neumann M, Ballard T, Muller V, Woolley M, et al.

Age-dependent cognitive decline and amygdala pathology in alpha- synuclein transgenic mice

NEUROBIOLOGY OF AGING. 2007 SEP; 28 (9): 1421-1435

1302

19934 Levy JA, Chelune GJ

Cognitive-behavioral profiles of Neurodegenerative dementias: Beyond Alzheimer's disease

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2007 DEC; 20 (4): 227-238

154

1303

20026 Zhu XW, Perry G, Smith MA

Two hits and you're out? A novel mechanistic hypothesis of Alzheimer disease

ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 191-204

132

1304

20219 Kwong LK, Uryu K, Trojanowski JQ, Lee VMY

TDP-43 proteinopathies: Neurodegenerative protein misfolding diseases without amyloidosis

NEUROSIGNALS. 2008; 16 (1): 41-51

1305

20319 Chesselet MF

In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?

EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 22-27

1306

20946 Ye L, Velasco A, Fraser G, Beach TG, Sue L, et al.

In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain

JOURNAL OF NEUROCHEMISTRY. 2008 MAY; 105 (4): 1428-1437

1307

21027 Braak H, Del Tredici K

Invited Article: Nervous system pathology in sporadic Parkinson disease

NEUROLOGY. 2008 MAY 13; 70 (20): 1916-1925

1308

21259 Deters N, Ittner LM, Gotz J

Divergent phosphorylation pattern of tau in P301L tau transgenic mice

EUROPEAN JOURNAL OF NEUROSCIENCE. 2008 JUL; 28 (1): 137-147

1309

21490 Park JY, Paik SR, Jou I, Park SM

Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: Implications for Parkinson's disease

GLIA. 2008 AUG 15; 56 (11): 1215-1223

1310

21559 Lo Bianco C, Shorter J, Regulier E, Lashuel H, Iwatsubo T, et al.

HsP104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease

JOURNAL OF CLINICAL INVESTIGATION. 2008 SEP; 118 (9): 3087-3097

Date / Author / Journal

LCS

GCS

LCR

1311

21918 de Vries HE, Witte M, Hondius D, Rozermuller AJM, Drukarch B, et al.

Nrf2-induced antioxidant Protection: A Promising target to counteract ROS-mediated damage in neurodegenerative disease?

FREE RADICAL BIOLOGY AND MEDICINE. 2008 NOV 15; 45 (10): 1375-1383

195

1312

21973 Aarsland D, Beyer MK, Kurz MW

Dementia in Parkinson's disease

CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 676-682

1313

22386 Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, et al.

Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation

JOURNAL OF NEUROCHEMISTRY. 2009 JAN; 108 (1): 33-43

1314

23119 van Rooijen BD, Claessens MMAE, Subramaniam V

Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2009 JUN; 1788 (6): 1271-1278

1315

23138 Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C

The genetics of Parkinson's syndromes: a critical review

CURRENT OPINION IN GENETICS & DEVELOPMENT. 2009 JUN; 19 (3): 254-265

1316

23498 Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, et al.

Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin

JOURNAL OF NEUROCHEMISTRY. 2009 AUG; 110 (3): 1082-1094

1317

23659 Riedel M, Goldbaum O, Richter-Landsberg C

alpha-Synuclein Promotes the Recruitment of Tau to Protein Inclusions in Oligodendroglial Cells: Effects of Oxidative and Proteolytic Stress

JOURNAL OF MOLECULAR NEUROSCIENCE. 2009 SEP; 39 (1-2): 226-234

1318

24025 Farin A, Liu CY, Langmoen IA, Apuzzo MLJ

BIOLOGICAL RESTORATION OF CENTRAL NERVOUS SYSTEM ARCHITECTURE AND FUNCTION: PART 3-STEM CELL- AND CELL-BASED APPLICATIONS AND REALITIES IN THE BIOLOGICAL MANAGEMENT OF CENTRAL NERVOUS SYSTEM DISORDERS: TRAUMATIC, VASCULAR, AND EPILEPSY DISORDERS

NEUROSURGERY. 2009 NOV; 65 (5): 831-859

165

1319

24042 Wang YP, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, et al.

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

HUMAN MOLECULAR GENETICS. 2009 NOV 1; 18 (21): 4153-4170

1320

24175 Botella JA, Bayersdorfer F, Gmeiner F, Schneuwly S

Modelling Parkinson's Disease in Drosophila

NEUROMOLECULAR MEDICINE. 2009 DEC; 11 (4): 268-280

Date / Author / Journal

1321

Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease

PARKINSONISM & RELATED DISORDERS. 2009 DEC; 15 (10): 721-727

118

1322

24261 Butterfield SM, Lashuel HA

Amyloidogenic Protein Membrane Interactions: Mechanistic Insight from Model Systems

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2010; 49 (33): 5628-5654

224

1323

24324 Hunter KU, Yarbrough C, Ciacci J

Gene- and Cell-Based Approaches for Neurodegenerative Disease

FRONTIERS IN BRAIN REPAIR. 2010; 671: 117-130

115

1324

24422 Run XQ, Liang ZH, Gong CX

Anesthetics and Tau Protein: Animal Model Studies

JOURNAL OF ALZHEIMERS DISEASE. 2010; 22: S49-S55

1325

24566 De Kimpe L, Scheper W

From Alpha to Omega with A beta: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimer's Disease

CURRENT MEDICINAL CHEMISTRY. 2010 JAN; 17 (3): 198-212

177

1326

24756 Nagai Y, Fujikake N, Popiel HA, Wada K

Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 188-197

114

1327

24791 Lemere CA, Masliah E

Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

NATURE REVIEWS NEUROLOGY. 2010 FEB; 6 (2): 108-119

131

1328

25075 Haque F, Pandey AP, Cambrea LR, Rochet JC, Hovis JS

Adsorption of alpha-Synuclein on Lipid Bilayers: Modulating the Structure and Stability ofProtein Assemblies

JOURNAL OF PHYSICAL CHEMISTRY B. 2010 MAR 25; 114 (11): 4070-4081

1329

25245 Wang MS, Boddapati S, Emadi S, Sierks MR

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model

BMC NEUROSCIENCE. 2010 APR 30; 11: Art. No. 57

1330

25271 Garbern JY, Neumann M, Trojanowski JQ, Lee VMY, Feldman G, et al.

A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition

BRAIN. 2010 MAY; 133: 1391-1402

Date / Author / Journal

LCS

GCS

LCR

1331

25319 Schwach G, Tschemmernegg M, Pfragner R, Ingolic E, Schreiner E, et al.

Establishment of Stably Transfected Rat Neuronal Cell Lines Expressing alpha-Synuclein GFP Fusion Proteins

JOURNAL OF MOLECULAR NEUROSCIENCE. 2010 MAY; 41 (1): 80-88

1332

25754 Buee L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, et al.

From tau phosphorylation to tau aggregation: what about neuronal death?

BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 967-972

1333

25939 Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, et al.

Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 AUG 20; 285 (34): 26304-26314

1334

25985 Castellani RJ, Rolston RK, Smith MA

Alzheimer Disease

DM DISEASE-A-MONTH. 2010 SEP; 56 (9): 484-546

303

1335

26539 Bosco DA, Landers JE

Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 779-790

157

1336

26563 Tenreiro S, Outeiro TF

Simple is good: yeast models of neurodegeneration

FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 970-979

1337

26596 Li J, Li XY, Feng DF, Pan DC

Biomarkers Associated With Diffuse Traumatic Axonal Injury: Exploring Pathogenesis, Early Diagnosis, and Prognosis

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2010 DEC; 69 (6): 1610-1618

1338

26617 Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, et al.

Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings

NEUROLOGICAL SCIENCES. 2010 DEC; 31 (6): 741-749

1339

26876 Braak H, Del Tredici K

The pathological process underlying Alzheimer's disease in individuals under thirty

ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 171-181

1340

26935 Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, et al.

Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review

NEUROLOGICAL SCIENCES. 2011 FEB; 32 (1): 9-16

Date / Author / Journal

LCS

GCS

LCR

1341

26951 Cho MK, Kim HY, Fernandez CO, Becker S, Zweckstetter M

Conserved core of amyloid fibrils of wild type and A30P mutant alpha- synuclein

PROTEIN SCIENCE. 2011 FEB; 20 (2): 387-395

1342

26959 Nasstrom T, Fagerqvist T, Barbu M, Karlsson M, Nikolajeff F, et al.

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties

FREE RADICAL BIOLOGY AND MEDICINE. 2011 FEB 1; 50 (3): 428-437

1343

27022 Soper JH, Kehm V, Burd CG, Bankaitis VA, Lee VMY

Aggregation of alpha-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis

JOURNAL OF MOLECULAR NEUROSCIENCE. 2011 MAR; 43 (3): 391-405

1344

2625 Trojanowski JQ, SCHMIDT ML, SHIN RW, BRAMBLETT GT, RAO D, et al.

ALTERED TAU AND NEUROFILAMENT PROTEINS IN NEURODEGENERATIVE DISEASES - DIAGNOSTIC IMPLICATIONS FOR ALZHEIMERS-DISEASE AND LEWY BODY DEMENTIAS

BRAIN PATHOLOGY. 1993 JAN; 3 (1): 45-54

187

1345

3985 SHIN RW, Lee VMY, Trojanowski JQ

NEUROFIBRILLARY PATHOLOGY AND ALUMINUM IN ALZHEIMERS-DISEASE

HISTOLOGY AND HISTOPATHOLOGY. 1995 OCT; 10 (4): 969-978

135

1346

4591 Mandell JW, Banker GA

A spatial gradient of tau protein phosphorylation in nascent axons

JOURNAL OF NEUROSCIENCE. 1996 SEP 15; 16 (18): 5727-5740

128

1347

4995 Dickson DW

The pathogenesis of senile plaques

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1997 APR; 56 (4): 321-339

136

360

167

1348

6066 Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, et al.

Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M

JOURNAL OF NEUROSCIENCE. 1998 JUN 1; 18 (11): 4008-4021

1349

6487 Gartner U, Janke C, Holzer M, Vanmechelen E, Arendt T

Postmortem changes in the phosphorylation state of tau-protein in the rat brain

NEUROBIOLOGY OF AGING. 1998 NOV-DEC; 19 (6): 535-543

1350

7733 Ekinci FJ, Shea TB

Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC

BRAIN RESEARCH. 1999 DEC 11; 850 (1-2): 207-216

Date / Author / Journal

1351

Morphological substrates of mental dysfunction in Lewy body disease: an update

ADVANCES IN DEMENTIA RESEARCH. 2000; : 185-212

150

1352

7822 Mizuno Y, Hattori N, Asakawa S, Shimura H, Mori H, et al.

Progress in familial Parkinson's disease

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2000; 28 (3): 143-157

1353

7837 Jellinger KA

Morphological substrates of mental dysfunction in Lewy body disease: an update

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 185-212

151

1354

8107 Chambers CB, Sigurdsson EM, Hejna MJ, Lorens SA, Lee JM, et al.

Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression

EXPERIMENTAL NEUROLOGY. 2000 MAR; 162 (1): 158-170

1355

8253 Probst A, Gotz J, Wiederhold KH, Tolnay M, Mistl C, et al.

Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

ACTA NEUROPATHOLOGICA. 2000 MAY; 99 (5): 469-481

155

1356

8493 Barbas H

Connections underlying the synthesis of cognition, memory, and emotion in primate prefrontal cortices

BRAIN RESEARCH BULLETIN. 2000 JUL 15; 52 (5): 319-330

200

183

1357

8586 van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, et al.

Neuropathology in mice expressing human alpha-synuclein

JOURNAL OF NEUROSCIENCE. 2000 AUG 15; 20 (16): 6021-6029

256

275

1358

8809 Wong NKY, He BP, Strong MJ

Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS)

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 NOV; 59 (11): 972-982

1359

8825 Arendt T

Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain

NEUROBIOLOGY OF AGING. 2000 NOV-DEC; 21 (6): 783-796

282

1360

8840 Yamada K, Nabeshima T

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

PHARMACOLOGY & THERAPEUTICS. 2000 NOV; 88 (2): 93-113

281

Date / Author / Journal

LCS

GCS

LCR

1361

8849 Julien JP, Beaulieu JM

Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2000 NOV 1; 180 (1-2): 7-14

1362

9005 Halliwell B

Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment

DRUGS & AGING. 2001; 18 (9): 685-716

422

414

1363

9572 Arendt T

Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2001 JUN; 19 (3): 231-245

280

1364

9787 Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, et al.

Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments

JOURNAL OF NEUROSCIENCE. 2001 AUG 15; 21 (16): 6026-6035

1365

9830 Miyasaka T, Morishima-Kawashima M, Ravid R, Kamphorst W, Nagashima K, et al.

Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 SEP; 60 (9): 872-884

1366

10817 Bian F, Nath R, Sobocinski G, Booher RN, Lipinski WJ, et al.

Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice

JOURNAL OF COMPARATIVE NEUROLOGY. 2002 MAY 6; 446 (3): 257-266

1367

11942 Riess O, Berg D, Kruger R, Schulz JB

Therapeutic strategies for Parkinson's disease based on data derived from genetic research

JOURNAL OF NEUROLOGY. 2003 FEB; 250: 3-10

1368

12244 Braak H, Rub U, Gai WP, Del Tredici K

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

JOURNAL OF NEURAL TRANSMISSION. 2003 MAY; 110 (5): 517-536

117

115

1369

12544 Mishizen-Eberz AJ, Guttmann RP, Giasson BI, Day GA, Hodara R, et al.

Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro

JOURNAL OF NEUROCHEMISTRY. 2003 AUG; 86 (4): 836-847

1370

12665 Lin H, Zhai JB, Nie ZY, Wu JH, Meinkoth JL, et al.

Neurofilament RNA causes neu rodegene ration with accumulation of ubiquitinated aggregates in cultured motor neurons

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 SEP; 62 (9): 936-950

Date / Author / Journal

LCS

GCS

LCR

1371

12685 Phinney AL, Horne P, Yang J, Janus C, Bergeron C, et al.

Mouse models of Alzheimer's disease: The long and filamentous road

NEUROLOGICAL RESEARCH. 2003 SEP; 25 (6): 590-600

121

1372

12751 Van Deerlin VM, Gill LH, Farmer JM, Trojanowski JQ, Lee VMY

Familial frontotemporal dementia: From gene discovery to clinical molecular diagnostics

CLINICAL CHEMISTRY. 2003 OCT; 49 (10): 1717-1725

1373

12898 Liem RKH, Leung CL

Neuronal intermediate filament overexpression and neurodegeneration in transgenic mice

EXPERIMENTAL NEUROLOGY. 2003 NOV; 184 (1): 3-8

1374

12914 Ling Y, Morgan K, Kalsheker N

Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2003 NOV; 35 (11): 1505-1535

308

1375

12919 Stefani M, Dobson CM

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

JOURNAL OF MOLECULAR MEDICINE-JMM. 2003 NOV; 81 (11): 678-699

491

200

1376

12930 Ardley HC, Scott GB, Rose SA, Tan NGS, Markham AF, et al.

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

MOLECULAR BIOLOGY OF THE CELL. 2003 NOV; 14 (11): 4541-4556

1377

13318 Gong CX, Liu F, Wu GX, Rossie S, Wegiel J, et al.

Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5

JOURNAL OF NEUROCHEMISTRY. 2004 JAN; 88 (2): 298-310

1378

13625 Zhou WB, Freed CR

Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 12; 279 (11): 10128-10135

1379

14016 Hoyer WG, Cherny D, Subramaniam V, Jovin TM

Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy

JOURNAL OF MOLECULAR BIOLOGY. 2004 JUN 25; 340 (1): 127-139

1380

14038 Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, et al.

Intra- and extracellular AB and PHF in clinically evaluated cases of Alzheimer's disease

HISTOLOGY AND HISTOPATHOLOGY. 2004 JUL; 19 (3): 823-844

125

Date / Author / Journal

LCS

GCS

LCR

1381

15382 Liazoghli D, Perreault S, Micheva KD, Desjardins M, Leclerc N

Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons

AMERICAN JOURNAL OF PATHOLOGY. 2005 MAY; 166 (5): 1499-1514

1382

15595 Masliah E, Rockenstein E, Adame A, Alford M, Crews L, et al.

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

NEURON. 2005 JUN 16; 46 (6): 857-868

103

1383

15661 Hernandez F, Engel T, Gomez-Ramos A, Perez M, Avila J

Characterization of Alzheimer paired helical filaments by electron microscopy

MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 121-125

1384

15920 Kuan WL, Barker RA

New therapeutic approaches to Parkinson's disease including neural transplants

NEUROREHABILITATION AND NEURAL REPAIR. 2005 SEP; 19 (3): 155-181

338

1385

16358 Smith WW, Jiang HB, Pei Z, Tanaka Y, Morita H, et al.

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity

HUMAN MOLECULAR GENETICS. 2005 DEC 15; 14 (24): 3801-3811

1386

16678 Khlistunova I, Biernat J, Wang YP, Pickhardt M, von Bergen M, et al.

Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JAN 13; 281 (2): 1205-1214

1387

16840 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K

Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation

JOURNAL OF ALZHEIMERS DISEASE. 2006 MAR; 9 (1): 1-12

119

1388

17184 Jenner P, Olanow CW

The pathogenesis of cell death in Parkinson's disease

NEUROLOGY. 2006 MAY 23; 66 (10): S24-S36

119

1389

17634 Engel T, Lucas JJ, Gomez-Ramos P, Moran MA, Avila J, et al.

Cooexpression of FTDP-17 tau and GSK-3 beta in transgenic mice induce tau polymerization and neurodegeneration

NEUROBIOLOGY OF AGING. 2006 SEP; 27 (9): 1258-1268

1390

17743 Chua CEL, Tang BL

alpha-synuclein and Parkinson's disease: the first roadblock

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2006 OCT-DEC; 10 (4): 837-846

Date / Author / Journal

1391

Characterization of two VQIXXK motifs for tau fibrillization in vitro

BIOCHEMISTRY. 2006 DEC 26; 45 (51): 15692-15701

1392

18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147

167

1393

19303 Korecka JA, Verhaagen J, Hol EM

Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease

REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 425-446

163

1394

19434 Chun W, Johnson GVW

Activation of glycogen synthase kinase 3 beta promotes the intermolecular association of tau - The use of fluorescence resonance energy transfer microscopy

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 10; 282 (32): 23410-23417

1395

19618 Schipper HM

The role of biologic markers in the diagnosis of Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2007 OCT; 3 (4): 325-332

1396

20022 Nunomura A, Moreira PI, Zhu XW, Cash AD, Smith MA, et al.

Role of oxidative insult and neuronal survival in Alzheimer's and Parkinson's diseases

ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 133-148

120

1397

20073 Aarsland D, Kurz M, Beyer M, Bronnick K, Nore SP, et al.

Early discriminatory diagnosis of dementia with Lewy bodies

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008; 25 (3): 195-205

100

1398

20143 Ding HP, Johnson GVW

The last tangle of tau

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 441-447

1399

20665 Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, et al.

The early neuropsychological and behavioral characteristics of Frontotemporal dementia

NEUROPSYCHOLOGY REVIEW. 2008 MAR; 18 (1): 91-102

1400

20713 Lee JT, Wheeler TC, Li L, Chin LS

Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death

HUMAN MOLECULAR GENETICS. 2008 MAR 15; 17 (6): 906-917

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records